Clarity Pharmaceuticals Success:
Clarity Pharmaceuticals reported a significant response in a patient with metastatic castrate-resistant prostate cancer.
The patient received two cycles of copper 67 Biss. PSMA, and after six months from the second dose, there was no evidence of PSA,...
Published 05/01/24